Idalid Franco, Sophia Kamran, and Anwaar Saeed were named health equity fellows by NRG Oncology, an NCI National Clinical Trials Network group, as a part of the organization’s Health Equity Fellowship Program. Fellows receive an award of $50,000 for two years with an end result of developing a new research protocol within NRG Oncology.
Biologic drugs play an important role in treating cancers such as breast cancer and lymphoma, but their high costs can add to the financial burden of cancer care. Now, lower-cost versions known as biosimilars are gaining ground, and a study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center suggests their growing use is associated with lower costs for both insurers and patients.
